The Michelson Prizes fund innovative, high-impact research in human immunology, vaccine discovery, and immunotherapy by early-career scientists using interdisciplinary approaches.
Funder: Michelson Medical Research Foundation
Due Dates (Anticipated): June 2027 (Full application) | October 2027 (Supplementary info for shortlisted applicants)
Funding Amounts: $150,000 per award for a one-year project; no indirect costs allowed.
Summary: Annual grants supporting early-career researchers with innovative, high-impact projects in human immunology, vaccine discovery, and immunotherapy.
Key Information: Applicants must be born on or after January 1, 1990 and dedicate at least 50% effort to the funded project.
The Michelson Prizes: Next Generation Grants are annual awards from the Michelson Medical Research Foundation designed to support early-career investigators advancing the fields of human immunology, vaccine discovery, and immunotherapy. The program specifically seeks high-risk, high-reward research that addresses major challenges in vaccine development and expands our fundamental understanding of immune processes. Projects from a broad range of disciplines—including clinical research, molecular biology, protein engineering, computer science, artificial intelligence, biophysics, and nanotechnology—are encouraged, provided they have clear relevance to human immunology and/or vaccine science. The program is open to international applicants and aims to foster transformative, interdisciplinary approaches that might not be funded through conventional mechanisms.